Supernus Pharmaceuticals | 销售成本

股票价格

54.73

每天变化

-1.02 -1.83%

每月一次

11.83%

每年

70.71%

Q1 预测

53.06

金融业

USD

USD 1.45B

现金及等价物

USD 151.37M

USD 47.53M

USD 644.18M

USD 338.17M

USD 42.21M

USD 13.82M

USD 48.5M

674

EPS每股收益

USD -0.07

股本和储备

USD 1.06B

USD 164.04M

债务利息支出

USD 910K

USD 2.28M

USD 400.38M

USD 3B

USD -45.12M

USD 197.75M

USD 13.82M

普通股股本

USD 57.12M

USD 110.38

USD -1.91M

USD 211.6M

销售和管理费用

USD 122.39M

USD 107.1M

贸易债权人

USD 107.8M

应收帐款人

USD 187.8M

	销售成本	更改		日
Abbott	USD 4.92B		535M	2025-12
ANI Pharmaceuticals	USD 122.88M		6.86M	2025-12
Aurora Cannabis	CAD 58.08M		11.99M	2025-09
Bristol-Myers Squibb	USD 4.92B		657M	2025-12
Canopy Growth	CAD 44.78M		9.32M	2025-09
Cara Therapeutics	USD 0		0	2025-03
Corcept Therapeutics	USD 2.54M		2.05M	2025-12
Eisai	JPY 51.08B		5.56B	2025-12
Eli Lilly	USD 3.37B		363.7M	2025-12
Novo Nordisk	DKK 15.15B		2.3B	2025-12
Pacira	USD 54.62M		6.02M	2025-12
Perrigo	USD 747.4M		81.2M	2025-12
Pfizer	USD 6.29B		2.12B	2025-12
Supernus Pharmaceuticals	USD 47.53M		4.24M	2025-12
United Therapeutics	USD 474.7M		373.8M	2025-12
Xeris Pharmaceuticals	USD 13.71M		1.81M	2025-09

Supernus Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.